Orphan drug coalition formed to attain permanent tax credit.
Executive Summary
ORPHAN DRUG COALITION FORMS TO ATTAIN PERMANENT TAX CREDIT in anticipation of the orphan drug tax credit's expiration May 31. The effort is being spearheaded by the National Organization for Rare Disorders and the Biotechnology Industry Organization with the support of the Washington, D.C. law firm Fox, Bennett & Turner.